These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1072 related items for PubMed ID: 9198851

  • 1. [Spironolactone: renaissance of anti-aldosterone therapy in heart failure?].
    Brilla CG, Schencking M, Scheer C, Rupp H.
    Praxis (Bern 1994); 1997 Apr 02; 86(14):566-74. PubMed ID: 9198851
    [Abstract] [Full Text] [Related]

  • 2. Collagen metabolism in cultured adult rat cardiac fibroblasts: response to angiotensin II and aldosterone.
    Brilla CG, Zhou G, Matsubara L, Weber KT.
    J Mol Cell Cardiol; 1994 Jul 02; 26(7):809-20. PubMed ID: 7966349
    [Abstract] [Full Text] [Related]

  • 3. Anti-aldosterone treatment and the prevention of myocardial fibrosis in primary and secondary hyperaldosteronism.
    Brilla CG, Matsubara LS, Weber KT.
    J Mol Cell Cardiol; 1993 May 02; 25(5):563-75. PubMed ID: 8377216
    [Abstract] [Full Text] [Related]

  • 4. Renin-angiotensin system and myocardial collagen matrix: modulation of cardiac fibroblast function by angiotensin II type 1 receptor antagonism.
    Brilla CG, Scheer C, Rupp H.
    J Hypertens Suppl; 1997 Dec 02; 15(6):S13-9. PubMed ID: 9493122
    [Abstract] [Full Text] [Related]

  • 5. Myocardial collagen matrix remodeling and congestive heart failure.
    Brilla CG, Rupp H.
    Cardiologia; 1994 Dec 02; 39(12 Suppl 1):389-93. PubMed ID: 7634301
    [Abstract] [Full Text] [Related]

  • 6. Cardioprotection by aldosterone receptor antagonism in heart failure. Part I. The role of aldosterone in heart failure.
    Dieterich HA, Wendt C, Saborowski F.
    Fiziol Cheloveka; 2005 Dec 02; 31(6):97-105. PubMed ID: 16366159
    [Abstract] [Full Text] [Related]

  • 7. Pharmacological modulation of cardiac fibroblast function.
    Brilla CG, Maisch B, Rupp H, Funck R, Zhou G, Weber KT.
    Herz; 1995 Apr 02; 20(2):127-34. PubMed ID: 7774864
    [Abstract] [Full Text] [Related]

  • 8. Regulation and role of myocardial collagen matrix remodeling in hypertensive heart disease.
    Funck RC, Wilke A, Rupp H, Brilla CG.
    Adv Exp Med Biol; 1997 Apr 02; 432():35-44. PubMed ID: 9433509
    [Abstract] [Full Text] [Related]

  • 9. Aldosterone and myocardial fibrosis in heart failure.
    Brilla CG.
    Herz; 2000 May 02; 25(3):299-306. PubMed ID: 10904856
    [Abstract] [Full Text] [Related]

  • 10. Aldosterone antagonism in addition to angiotensin-converting enzyme inhibitors in heart failure.
    Bauersachs J, Fraccarollo D.
    Minerva Cardioangiol; 2003 Apr 02; 51(2):155-64. PubMed ID: 12783071
    [Abstract] [Full Text] [Related]

  • 11. [Left-ventricular hypertrophy as a cardiac risk factor: role of the renin-angiotensin-aldosterone system].
    Erne P.
    Praxis (Bern 1994); 1996 Feb 20; 85(8):227-33. PubMed ID: 8701189
    [Abstract] [Full Text] [Related]

  • 12. Mineralocorticoid receptor antagonism ameliorates left ventricular diastolic dysfunction and myocardial fibrosis in mildly symptomatic patients with idiopathic dilated cardiomyopathy: a pilot study.
    Izawa H, Murohara T, Nagata K, Isobe S, Asano H, Amano T, Ichihara S, Kato T, Ohshima S, Murase Y, Iino S, Obata K, Noda A, Okumura K, Yokota M.
    Circulation; 2005 Nov 08; 112(19):2940-5. PubMed ID: 16275882
    [Abstract] [Full Text] [Related]

  • 13. Myocardial fibrosis associated with aldosterone or angiotensin II administration: attenuation by calcium channel blockade.
    Ramires FJ, Sun Y, Weber KT.
    J Mol Cell Cardiol; 1998 Mar 08; 30(3):475-83. PubMed ID: 9515025
    [Abstract] [Full Text] [Related]

  • 14. Induction of cardiac fibrosis by aldosterone.
    Lijnen P, Petrov V.
    J Mol Cell Cardiol; 2000 Jun 08; 32(6):865-79. PubMed ID: 10888242
    [Abstract] [Full Text] [Related]

  • 15. The renin-angiotensin-aldosterone system and myocardial collagen matrix remodelling in congestive heart failure.
    Brilla CG, Rupp H, Funck R, Maisch B.
    Eur Heart J; 1995 Dec 08; 16 Suppl O():107-9. PubMed ID: 8682074
    [Abstract] [Full Text] [Related]

  • 16. Aldosterone synthase inhibition improves cardiovascular function and structure in rats with heart failure: a comparison with spironolactone.
    Mulder P, Mellin V, Favre J, Vercauteren M, Remy-Jouet I, Monteil C, Richard V, Renet S, Henry JP, Jeng AY, Webb RL, Thuillez C.
    Eur Heart J; 2008 Sep 08; 29(17):2171-9. PubMed ID: 18586661
    [Abstract] [Full Text] [Related]

  • 17. [Cardiac structure-function relationship and the renin-angiotensin-aldosterone system in hypertensive heart disease].
    Funck RC, Wilke A, Rupp H, Maisch B, Brilla CG.
    Herz; 1995 Oct 08; 20(5):330-9. PubMed ID: 7498880
    [Abstract] [Full Text] [Related]

  • 18. Effect of renin-angiotensin-aldosterone system triple blockade on non-diabetic renal disease: addition of an aldosterone blocker, spironolactone, to combination treatment with an angiotensin-converting enzyme inhibitor and angiotensin II receptor blocker.
    Furumatsu Y, Nagasawa Y, Tomida K, Mikami S, Kaneko T, Okada N, Tsubakihara Y, Imai E, Shoji T.
    Hypertens Res; 2008 Jan 08; 31(1):59-67. PubMed ID: 18360019
    [Abstract] [Full Text] [Related]

  • 19. Role of aldosterone in angiotensin II-induced cardiac and aortic inflammation, fibrosis, and hypertrophy.
    Neves MF, Amiri F, Virdis A, Diep QN, Schiffrin EL, CIHR Multidisciplinary Research Group on Hypertension.
    Can J Physiol Pharmacol; 2005 Nov 08; 83(11):999-1006. PubMed ID: 16391708
    [Abstract] [Full Text] [Related]

  • 20. Aldosterone synthase (CYP11B2) expression and myocardial fibrosis in the failing human heart.
    Satoh M, Nakamura M, Saitoh H, Satoh H, Akatsu T, Iwasaka J, Masuda T, Hiramori K.
    Clin Sci (Lond); 2002 Apr 08; 102(4):381-6. PubMed ID: 11914098
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 54.